GB9720899D0 - Condensed heterocyclic compounds - Google Patents

Condensed heterocyclic compounds

Info

Publication number
GB9720899D0
GB9720899D0 GBGB9720899.5A GB9720899A GB9720899D0 GB 9720899 D0 GB9720899 D0 GB 9720899D0 GB 9720899 A GB9720899 A GB 9720899A GB 9720899 D0 GB9720899 D0 GB 9720899D0
Authority
GB
United Kingdom
Prior art keywords
heterocyclic compounds
condensed heterocyclic
condensed
compounds
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9720899.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Priority to GBGB9720899.5A priority Critical patent/GB9720899D0/en
Publication of GB9720899D0 publication Critical patent/GB9720899D0/en
Priority to EP98956836A priority patent/EP1019380A2/fr
Priority to JP2000513839A priority patent/JP2001518469A/ja
Priority to AU13343/99A priority patent/AU1334399A/en
Priority to PCT/EP1998/006051 priority patent/WO1999016753A2/fr
Priority to CA002302025A priority patent/CA2302025A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GBGB9720899.5A 1997-10-01 1997-10-01 Condensed heterocyclic compounds Ceased GB9720899D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9720899.5A GB9720899D0 (en) 1997-10-01 1997-10-01 Condensed heterocyclic compounds
EP98956836A EP1019380A2 (fr) 1997-10-01 1998-09-23 Composes 3-oxo-propanenitrile tricycliques
JP2000513839A JP2001518469A (ja) 1997-10-01 1998-09-23 三環式３−オキソ−プロパンニトリル化合物
AU13343/99A AU1334399A (en) 1997-10-01 1998-09-23 Tricyclic 3-oxo-propanenitrile compounds
PCT/EP1998/006051 WO1999016753A2 (fr) 1997-10-01 1998-09-23 Composes 3-oxo-propanenitrile tricycliques
CA002302025A CA2302025A1 (fr) 1997-10-01 1998-09-23 Composes 3-oxo-propanenitrile tricycliques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9720899.5A GB9720899D0 (en) 1997-10-01 1997-10-01 Condensed heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB9720899D0 true GB9720899D0 (en) 1997-12-03

Family

ID=10819928

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9720899.5A Ceased GB9720899D0 (en) 1997-10-01 1997-10-01 Condensed heterocyclic compounds

Country Status (6)

Country Link
EP (1) EP1019380A2 (fr)
JP (1) JP2001518469A (fr)
AU (1) AU1334399A (fr)
CA (1) CA2302025A1 (fr)
GB (1) GB9720899D0 (fr)
WO (1) WO1999016753A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10021900A1 (de) 2000-05-08 2001-11-15 Bayer Ag Phenyl-substituierte 2-Enamino-Ketonitrile
UY30377A1 (es) * 2006-06-02 2008-01-02 Elan Pharm Inc Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842099A (en) * 1969-10-06 1974-10-15 Teikoku Hormune Mfg Co Ltd Naphtho(2,1-d)isoxazole derivatives
FI71129C (fi) * 1979-06-11 1986-11-24 Ciba Geigy Ag Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
GB2127809B (en) * 1982-09-28 1986-03-12 Ciba Geigy Ag Certain b-oxo-a-carbamoyl-pyrrolepropionitriles
US4816467A (en) * 1987-01-09 1989-03-28 Farmitalia Carlo Erba S.R.L Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use
GB8814586D0 (en) * 1988-06-20 1988-07-27 Erba Carlo Spa Tricyclic 3-oxo-propanenitrile derivatives & process for their preparation
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
GB2227741B (en) * 1989-02-06 1992-08-05 Erba Carlo Spa Condensed 3-oxo-propanenitrile derivatives and process for their preparation
GB8916290D0 (en) * 1989-07-17 1989-08-31 Erba Carlo Spa Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis
JP3148960B2 (ja) * 1993-04-12 2001-03-26 コニカ株式会社 写真用シアンカプラー
JP3542826B2 (ja) * 1994-07-11 2004-07-14 帝国臓器製薬株式会社 新規な二環式化合物縮合［２，１−ｄ］イソキサゾール−３−カルボン酸誘導体

Also Published As

Publication number Publication date
CA2302025A1 (fr) 1999-04-08
JP2001518469A (ja) 2001-10-16
WO1999016753A3 (fr) 1999-05-20
EP1019380A2 (fr) 2000-07-19
WO1999016753A2 (fr) 1999-04-08
AU1334399A (en) 1999-04-23

Similar Documents

Publication Publication Date Title
HK1025322A1 (en) Novel spiroazabicyclic heterocyclic compounds
EG24041A (en) New heterocyclic compounds
IL132170A0 (en) Novel heterocyclic compounds
GB9715892D0 (en) Heterocyclic compounds
GB9602294D0 (en) Heterocyclic compounds
GB9617305D0 (en) Heterocyclic compounds
ZA981920B (en) Novel heterocyclic compounds
GB9706294D0 (en) Heterocyclic compound
GB9720899D0 (en) Condensed heterocyclic compounds
ZA985448B (en) Novel heterocyclic compounds
GB9716103D0 (en) Condensed heterocyclic compounds
PL336639A1 (en) Novel heterocyclic compounds
EP0900204A4 (fr) Composes heterocycliques
GB9720901D0 (en) Condensed benzothiopyranic compounds
EP0900217A4 (fr) Composes heterocycliques
EP0900219A4 (fr) Composes heterocycliques
EP0912183A4 (fr) Composes heterocycliques
GB9716378D0 (en) Heterocyclic compounds
ZA989421B (en) Heterocyclic compounds
ZA981177B (en) Heterocyclic compounds
GB9801058D0 (en) Heterocyclic compounds
GB9719237D0 (en) Heterocyclic compounds
GB9715735D0 (en) Heterocyclic compounds
GB9715734D0 (en) Heterocyclic compounds
GB9702945D0 (en) Heterocyclic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)